Kyverna Therapeutics Inc. (KYTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kyverna Therapeutics Inc.

    NASDAQ: KYTX · Real-Time Price · USD
    5.52
    -0.56 (-9.21%)
    At close: Oct 03, 2025, 3:59 PM
    5.51
    -0.18%
    Pre-market: Oct 06, 2025, 07:36 AM EDT

    Kyverna Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
    PE Ratio
    		 -0.79 -0.47 -1.08 -1.53 -2.92 -5.01 -15.65 -20.91 -24.7 -17.37 -38.06
    PEG Ratio
    		 0.14 -0.03 -0.12 -0.08 0.07 -0.04 -0.47 -1.05 0.82 -0.15 n/a
    PS Ratio
    		 n/a n/a 79.85 n/a n/a n/a n/a n/a n/a n/a 4.59K
    PB Ratio
    		 0.72 0.37 0.61 0.70 1.01 1.48 -9.84 -11.57 3.58 16.58 -17.48
    P/FCF Ratio
    		 -4.13 -1.86 -4.3 -7.65 -13.36 -20.52 -68.45 -113.58 -114.87 -67.4 -146.5
    P/OCF Ratio
    		 -4.15 -1.86 -4.36 -7.68 -13.93 -20.96 -69.68 -116.19 -114.9 -67.56 -146.7
    OCF/S Ratio
    		 n/a n/a -18.31 n/a n/a n/a n/a n/a n/a n/a -31.27
    Debt / Equity Ratio
    		 0.03 0.03 0.03 0.03 0.03 0.03 -0.07 -0.09 0.03 n/a -0.14
    Quick Ratio
    		 5.39 7.44 8.61 10.50 14.86 17.17 3.05 4.71 17.17 n/a 4.45
    Current Ratio
    		 5.39 7.44 8.61 10.50 14.86 17.17 3.05 4.71 17.17 n/a 4.45
    Asset Turnover
    		 n/a n/a 0.01 n/a n/a n/a n/a n/a n/a n/a 0.00
    Interest Coverage
    		 -3.17K -1.9K -1.52K -1.21K -857.31 -667.23 -454.83 -325.64 -289.17 -260.11 -214.02
    Return on Equity
    		 -0.23 -0.2 -0.14 -0.11 -0.09 -0.07 0.16 0.14 -0.04 -0.24 0.11
    Return on Assets
    		 -0.19 -0.17 -0.12 -0.1 -0.08 -0.07 -0.27 -0.17 -0.03 n/a -0.13
    Return on Invested Capital
    		 -0.23 -0.21 -0.15 -0.12 -0.1 -0.08 -0.37 -0.21 -0.04 n/a -0.15
    Dividend Yield
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a -0.28 n/a n/a n/a n/a n/a n/a n/a -0.33
    Net Profit Margin
    		 n/a n/a -18.52 n/a n/a n/a n/a n/a n/a n/a -30.13
    Pretax Profit Margin
    		 n/a n/a -18.52 n/a n/a n/a n/a n/a n/a n/a -30.13
    Operating Profit Margin
    		 n/a n/a -20.28 n/a n/a n/a n/a n/a n/a n/a -31.12
    FCF Margin
    		 n/a n/a -18.57 n/a n/a n/a n/a n/a n/a n/a -31.31
    EBITDA Margin
    		 n/a n/a -18.23 n/a n/a n/a n/a n/a n/a n/a -28.66

    Add to Watchlist